Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Fresenius Medical Care Ag ADR (FMS)

Fresenius Medical Care Ag ADR (FMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Fresenius Medical Care appoints Charles Hugh-Jones as Global Chief Medical Officer and member of the Management Board

BAD HOMBURG, Germany , Dec. 10, 2025 /PRNewswire/ -- The Supervisory Board of Fresenius Medical Care, the world's leading provider of products and services for individuals with renal disease, has...

FMS : 24.05 (+0.38%)
Fresenius Medical Care further accelerates organic revenue development and achieves an inflection in earnings growth, delivering 28% operating income growth in the third quarter of 2025

BAD HOMBURG, Germany , Nov. 4, 2025 /PRNewswire/ -- "In Q3 of 2025, we continued the momentum and further accelerated revenue growth. Conversion into operating income 2 growth increased as...

FMS : 24.05 (+0.38%)
Fresenius Medical Care highlights real-world advances in hemodiafiltration and AI at ASN Kidney Week 2025

BAD HOMBURG, Germany , Oct. 30, 2025 /PRNewswire/ -- Fresenius Medical Care AG (FME), the world's leading provider of products and services for people with kidney diseases, will present new research...

FMS : 24.05 (+0.38%)
Fresenius Medical Care (FMS) was downgraded to a Sell Rating at Bank of America Securities

Bank of America Securities analyst Marianne Bulot downgraded Fresenius Medical Care to a Sell today and set a price target of $22.00. The company’s shares opened today at $26.70.Elevate Your Investing...

FMS : 24.05 (+0.38%)
Bank of America Securities downgrades Fresenius Medical Care AG & Co. KGaA (0H9X) to a Sell

Fresenius Medical Care AG & Co. KGaA received a Sell rating and a €38.00 price target from Bank of America Securities analyst Anna Ractliffe today. The company’s shares closed yesterday at €47.55.Elevate...

FMS : 24.05 (+0.38%)
Fresenius Medical Care appoints Joseph Turk as new Management Board Member for Care Enablement

BAD HOMBURG, Germany , Oct. 1, 2025 /PRNewswire/ -- The Supervisory Board of Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with...

FMS : 24.05 (+0.38%)
Is DaVita Stock Underperforming the Nasdaq?

As DaVita has considerably underperformed the Nasdaq recently, analysts remain cautious about the stock’s prospects.

$NASX : 23,613.31 (+0.22%)
FMS : 24.05 (+0.38%)
DVA : 114.41 (-0.27%)
Fresenius Medical Care advances its FME Reignite strategy by increasing ownership in its Value-Based Care asset and appointing a new leader for the operating segment

BAD HOMBURG, Germany , Sept. 18, 2025 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, today...

FMS : 24.05 (+0.38%)
The $1.4 Trillion Cardiovascular Disease Crisis: Why Revolutionary Blood Purification Could Transform Treatment Access

Cardiovascular disease remains the world's leading cause of death, claiming more than 17.9 million lives annually according to the World Health Organization . Despite decades of medical advances, existing...

RMTI : 0.8092 (-0.01%)
FMS : 24.05 (+0.38%)
PFE : 25.02 (-0.04%)
DVA : 114.41 (-0.27%)
SIGY : 1.7099 (-10.01%)
Encompass Health Q2 Earnings Beat Estimates, Stock Up 7.4%

Shares of Encompass Health Corp EHC have risen 7.4% since it reported second-quarter 2025 results on Aug. 4. The quarterly results were aided by strong net patient revenue per discharge and capacity expansion...

EHC : 107.11 (unch)
WST : 276.66 (-0.30%)
FMS : 24.05 (+0.38%)
THC : 197.77 (-0.50%)

Barchart Exclusives

AI Bubble Fears Scaring You Off? Buy This Magnificent 7 Stock for Stability.
Apple has long been seen as an AI laggard. However, the stock could fit into portfolios of investors worried about an AI bubble. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar